دورية أكاديمية
Sex-related differences in oncological surgery and postoperative outcomes: comprehensive, nationwide study in France.
| العنوان: | Sex-related differences in oncological surgery and postoperative outcomes: comprehensive, nationwide study in France. |
|---|---|
| المؤلفون: | Jochum F; Residual Tumour and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France.; Department of Gynaecology, Strasbourg University Hospital, Strasbourg, France., Hamy AS; Residual Tumour and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France.; Department of Medical Oncology, Institut Curie, Université Paris Cité, Paris, France., Gougis P; Residual Tumour and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France., Dumas É; Residual Tumour and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France., Grandal B; Residual Tumour and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France.; Department of Breast and Gynaecological Surgery, Institut Curie, Paris, Université Paris Cité, Paris, France., Sauzey M; Residual Tumour and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France.; Department of Breast and Gynaecological Surgery, Institut Curie, Paris, Université Paris Cité, Paris, France., Laas E; Department of Breast and Gynaecological Surgery, Institut Curie, Paris, Université Paris Cité, Paris, France., Feron JG; Department of Breast and Gynaecological Surgery, Institut Curie, Paris, Université Paris Cité, Paris, France., Fourchotte V; Department of Breast and Gynaecological Surgery, Institut Curie, Paris, Université Paris Cité, Paris, France., Gaillard T; Department of Breast and Gynaecological Surgery, Institut Curie, Paris, Université Paris Cité, Paris, France., Girard N; Department of Breast and Gynaecological Surgery, Institut Curie, Paris, Université Paris Cité, Paris, France., Pauly L; Department of Breast and Gynaecological Surgery, Institut Curie, Paris, Université Paris Cité, Paris, France., Gauroy E; Department of Breast and Gynaecological Surgery, Institut Curie, Paris, Université Paris Cité, Paris, France., Darrigues L; Department of Breast and Gynaecological Surgery, Institut Curie, Paris, Université Paris Cité, Paris, France., Hotton J; Department of Surgical Oncology, Institut Godinot, Reims, France., Lecointre L; Department of Gynaecology, Strasbourg University Hospital, Strasbourg, France., Reyal F; Residual Tumour and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France.; Department of Breast and Gynaecological Surgery, Institut Curie, Paris, Université Paris Cité, Paris, France., Lecuru F; Department of Breast and Gynaecological Surgery, Institut Curie, Paris, Université Paris Cité, Paris, France., Akladios C; Department of Gynaecology, Strasbourg University Hospital, Strasbourg, France. |
| المصدر: | The British journal of surgery [Br J Surg] 2024 Aug 02; Vol. 111 (8). |
| نوع المنشور: | Journal Article; Observational Study |
| اللغة: | English |
| بيانات الدورية: | Publisher: Oxford University Press Country of Publication: England NLM ID: 0372553 Publication Model: Print Cited Medium: Internet ISSN: 1365-2168 (Electronic) Linking ISSN: 00071323 NLM ISO Abbreviation: Br J Surg Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2021- : [Oxford] : Oxford University Press Original Publication: [Bristol, England : Baltimore : John Wright & Sons ; Williams & Wilkins Co. |
| مواضيع طبية MeSH: | Neoplasms*/surgery , Neoplasms*/mortality , Neoplasms*/epidemiology, Humans ; Female ; France/epidemiology ; Male ; Middle Aged ; Aged ; Sex Factors ; Adult ; Reoperation/statistics & numerical data ; Postoperative Complications/epidemiology ; Postoperative Complications/etiology ; Aged, 80 and over |
| مستخلص: | Background: The main objective of this study was to undertake an exhaustive investigation of sex-related differences in cancer surgery. Methods: This observational study used data from the French national health insurance system database covering 98.8% of the population. Patients diagnosed with non-sex-specific solid invasive cancers between January 2018 and December 2019 were included. The main outcomes were likelihood of undergoing cancer surgery, type of oncological surgery performed, and associated 30-, 60-, and 90-day postoperative reoperation and mortality rates, by sex. Results: For the 367 887 patients included, women were 44% more likely than men to undergo cancer surgery (OR 1.44, 95% c.i. 1.31 to 1.59; P < 0.001). However, the likelihood of surgery decreased with advancing age (OR 0.98, 0.98 to 0.98; P < 0.001), and with increasing number of co-morbid conditions (OR 0.95, 0.95 to 0.96; P < 0.001), especially in women. Men had higher 90-day reoperation (21.2 versus 18.8%; P < 0.001) and mortality (1.2 versus 0.9%; P < 0.001) rates than women, overall, and for most cancer types, with the exception of bladder cancer, for which the 90-day mortality rate was higher among women (1.8 versus 1.4%; P < 0.001). After adjustment for age, number of co-morbid conditions, and surgical procedure, 90-day mortality remained higher in men (OR 1.16, 1.07 to 1.26; P < 0.001), and men were 21% more likely than women to undergo reoperation within 90 days (OR 1.21, 1.18 to 1.23; P < 0.001). Conclusion: Women were much more likely than men to undergo cancer surgery than men, but the likelihood of surgery decreased with advancing age and with increasing number of co-morbid conditions, especially in women. These findings highlight a need for both increased awareness and strategies to ensure gender equality in access to oncological surgical treatment and improved outcomes. (© The Author(s) 2024. Published by Oxford University Press on behalf of BJS Foundation Ltd.) |
| References: | J Cancer Res Clin Oncol. 2020 May;146(5):1169-1196. (PMID: 32246217) Dis Colon Rectum. 2009 Dec;52(12):1982-91. (PMID: 19959975) J Clin Oncol. 2022 May 1;40(13):1474-1486. (PMID: 35119908) Res Integr Peer Rev. 2016 May 03;1:2. (PMID: 29451543) Surg Endosc. 2016 Sep;30(9):3965-75. (PMID: 26694185) J Natl Cancer Inst. 2021 Nov 2;113(11):1551-1560. (PMID: 33837791) Cancer. 2019 Sep 1;125(17):3033-3039. (PMID: 31090932) JAMA. 2004 Mar 10;291(10):1238-45. (PMID: 15010446) Cancer. 2014 Feb 15;120(4):555-61. (PMID: 24496869) EClinicalMedicine. 2023 Nov 01;65:102298. (PMID: 37965434) J Thorac Dis. 2019 Apr;11(4):1475-1484. (PMID: 31179090) Urol Int. 2015;94(1):37-44. (PMID: 25139297) Endocrinology. 2022 Jun 1;163(6):. (PMID: 35560216) World J Gastroenterol. 2015 May 7;21(17):5167-75. (PMID: 25954090) Lancet. 2019 Jun 15;393(10189):2440-2454. (PMID: 31155275) Eur J Cancer. 2023 Jul;187:114-123. (PMID: 37146505) Oncogenesis. 2023 Sep 4;12(1):44. (PMID: 37666817) Cancer. 2016 Jul 1;122(13):2012-20. (PMID: 27224661) J Public Health (Oxf). 2008 Jun;30(2):194-201. (PMID: 18445612) Langenbecks Arch Surg. 2020 Feb;405(1):71-80. (PMID: 32002628) EMBO Rep. 2012 Jun 29;13(7):596-603. (PMID: 22699937) Ann Epidemiol. 2020 Jun;46:14-19. (PMID: 32532368) |
| تواريخ الأحداث: | Date Created: 20240816 Date Completed: 20240816 Latest Revision: 20240818 |
| رمز التحديث: | 20240818 |
| مُعرف محوري في PubMed: | PMC11327872 |
| DOI: | 10.1093/bjs/znae179 |
| PMID: | 39150046 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1365-2168 |
|---|---|
| DOI: | 10.1093/bjs/znae179 |